Cargando…
MicroRNA-Mediated Metabolic Reprograming in Renal Cancer
Metabolic reprogramming is one of the hallmarks of renal cell cancer (RCC). We hypothesized that altered metabolism of RCC cells results from dysregulation of microRNAs targeting metabolically relevant genes. Combined large-scale transcriptomic and metabolic analysis of RCC patients tissue samples r...
Autores principales: | Bogusławska, Joanna, Popławski, Piotr, Alseekh, Saleh, Koblowska, Marta, Iwanicka-Nowicka, Roksana, Rybicka, Beata, Kędzierska, Hanna, Głuchowska, Katarzyna, Hanusek, Karolina, Tański, Zbigniew, Fernie, Alisdair R., Piekiełko-Witkowska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966432/ https://www.ncbi.nlm.nih.gov/pubmed/31756931 http://dx.doi.org/10.3390/cancers11121825 |
Ejemplares similares
-
Coordinated reprogramming of renal cancer transcriptome, metabolome and secretome associates with immune tumor infiltration
por: Poplawski, Piotr, et al.
Publicado: (2023) -
TGF-β1 affects the renal cancer miRNome and regulates tumor cells proliferation
por: Hanusek, Karolina, et al.
Publicado: (2022) -
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
por: Kędzierska, Hanna, et al.
Publicado: (2016) -
Correction: Kędzierska, H., et al. Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer. Int. J. Mol. Sci. 2016, 17, 1598
por: Kędzierska, Hanna, et al.
Publicado: (2020) -
Renal cancer secretome induces migration of mesenchymal stromal cells
por: Popławski, Piotr, et al.
Publicado: (2023)